about
CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies.BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms.A quite exceptional cause of recurrent hemoptysis.Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma.Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.Thymic carcinomas: clinicopathologic study of 37 cases from a single institution.Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.[Thymoma with epithelial micronodules and lymphoid hyperplasia: six cases of a rare and equivocal subtype].Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion.Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumoursGranular cell tumours of the lower respiratory tractHeart tumors in children and adults: clinicopathological study of 59 patients from a surgical center[Pulmonary fibrosis in Hermansky-Pudlak syndrome is not fully usual]Chest wall resection for invasive lung carcinoma, soft tissue sarcoma, and other types of malignancy. Pathologic aspects in a series of 107 patientsLymph node pathology in pulmonary veno-occlusive disease and pulmonary capillary heamangiomatosisFatal giant cell myocarditis after thymoma resection in myasthenia gravisGlut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes[Rythmic-pathology: the French national pathology network for thymic epithelial tumours]Cholesteroloma: a rare thymic pseudotumor
P50
Q38720446-EA1C646C-A1CF-4C66-A650-07767C0DD3E5Q39218460-AEA734FE-542E-46B1-B113-794E91ECD7C2Q40387149-967631F1-DAAB-4EFA-B60D-E756A5229D0BQ43418118-FC7826AC-8B13-4D61-93E4-69826ECA2252Q47120303-9E73FD3A-F884-40BB-9A5B-4C2B49109B90Q47434868-E5FE2A87-49EF-45E1-B303-0252236E0AF7Q48789174-0E7FDA82-5853-49AE-BB83-0C0414637ED1Q51280693-C95A584B-12D5-4EF9-A910-F63C9371B398Q51702724-7A6529D1-317F-4A49-A0F6-53381A56C7C5Q53953702-F166DDE1-B103-41DA-937D-2380E532B0D7Q54214606-243D6253-C7EF-45A9-B1BF-A011D08ED3CEQ54331978-98842F10-6602-4815-BD99-FB172F8FFD3FQ59799214-55BE561B-7855-4DB2-8EF6-F2D38863CD72Q70789106-75EB7062-CB97-499B-B83D-B27A95772E5FQ79544426-8D9054AD-9980-4672-9A53-014AF56FA0C4Q79668026-6D6FCD74-5F0F-4411-BA77-8C41AEB27CA1Q80410440-8AC72734-CFC2-4B2C-A623-3CD8C36FEFA5Q81449350-A49D37E9-90E3-40CD-8053-DB12DB67A57AQ82360290-8792D306-815A-48DC-8EBC-96F1349B1297Q86621425-48CE9091-9F07-414F-9372-F5EA88E53007Q87445351-D9E4DAF6-8933-40C9-B9FB-B82638153BBDQ89087390-3AE4EA0E-8B97-4429-A55B-40D81A87D5A3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vincent Thomas de Montpréville
@ast
Vincent Thomas de Montpréville
@en
Vincent Thomas de Montpréville
@es
Vincent Thomas de Montpréville
@fr
Vincent Thomas de Montpréville
@nl
Vincent Thomas de Montpréville
@sl
type
label
Vincent Thomas de Montpréville
@ast
Vincent Thomas de Montpréville
@en
Vincent Thomas de Montpréville
@es
Vincent Thomas de Montpréville
@fr
Vincent Thomas de Montpréville
@nl
Vincent Thomas de Montpréville
@sl
prefLabel
Vincent Thomas de Montpréville
@ast
Vincent Thomas de Montpréville
@en
Vincent Thomas de Montpréville
@es
Vincent Thomas de Montpréville
@fr
Vincent Thomas de Montpréville
@nl
Vincent Thomas de Montpréville
@sl
P106
P21
P31
P496
0000-0001-7490-4000